Subscribe Become an Author Sign Up Log In

Insitro

Company
Founded
2018
Status
Private
Geography
United States of America based
Funding
$100.0 M

About

A constellation of technologies now allows us to construct, perturb, and observe biological model systems in the laboratory, allowing the generation of biomolecular data at unprecedented breadth and scale. At the same time, the tools of data science and machine learning are now solving problems previously thought to be decades away from solution.

We aim to combine these technologies to develop a new approach to drug development that might help us cure more people, sooner, and at a much lower cost.

Research focus
  • Biology research (Target identification/validation)
  • Data mining / Ontology building

Investing history

2019Series A100.0

Industry Partnerships

YearPartnerFocus
2019Gilead